Biovie Inc

Company Profile

Biovie Inc had its IPO on 2014-05-05 under the ticker symbol BIVI.

The company operates in the Healthcare sector and Biotechnology industry. Biovie Inc has a staff strength of 13 employees.

Stock update

Shares of Biovie Inc opened at $3.52 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.32 - $3.72, and closed at $3.49.

This is a -3.32% slip from the previous day's closing price.

A total volume of 282,659 shares were traded at the close of the day’s session.

In the last one week, shares of Biovie Inc have increased by +12.95%.

Biovie Inc's Key Ratios

Biovie Inc has a market cap of $202.81 million, indicating a price to book ratio of 62.9978 and a price to sales ratio of 0.

In the last 12-months Biovie Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-43166128. The EBITDA ratio measures Biovie Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Biovie Inc’s operating margin was 0% while its return on assets stood at -76% with a return of equity of -310.88%.

In Q1, Biovie Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Biovie Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.81 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Biovie Inc’s profitability.

Biovie Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -13.3491. Its price to sales ratio in the trailing 12-months stood at 0.

Biovie Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$45.18 million

Total Liabilities

$16.00 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Biovie Inc ended 2024 with $45.18 million in total assets and $0 in total liabilities. Its intangible assets were valued at $45.18 million while shareholder equity stood at $21.72 million.

Biovie Inc ended 2024 with $0 in deferred long-term liabilities, $16.00 million in other current liabilities, 3613.00 in common stock, $-292113766.00 in retained earnings and $345711.00 in goodwill. Its cash balance stood at $31.28 million and cash and short-term investments were $43.80 million. The company’s total short-term debt was $6,434,382 while long-term debt stood at $7.41 million.

Biovie Inc’s total current assets stands at $44.05 million while long-term investments were $0 and short-term investments were $12.52 million. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.

In 2024, Biovie Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Biovie Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$3.49

52-Week High

$14.38

52-Week Low

$1.325

Analyst Target Price

$9.75

Biovie Inc stock is currently trading at $3.49 per share. It touched a 52-week high of $14.38 and a 52-week low of $14.38. Analysts tracking the stock have a 12-month average target price of $9.75.

Its 50-day moving average was $4.1 and 200-day moving average was $6.16 The short ratio stood at 3.06 indicating a short percent outstanding of 0%.

Around 5570.2% of the company’s stock are held by insiders while 321% are held by institutions.